Stem Cell Therapy for Traumatic Brain Injury in Istanbul

Neuropsychological assessment, imaging review, the route and the number of administrations are the main variables, and rehabilitation is quoted separately because it is a separate service. Our patient coordination team itemizes each one in writing and states the position if our review finds treatment is not appropriate for you.

Yes - the chronic phase is where most of our TBI case reviews sit. Time since injury matters less than what is driving the symptoms now, which is why our team looks for treatable contributors such as sleep disorder, vestibular or visual dysfunction, hormone deficiency, mood and medication effects before proposing anything.

It is assessed with the same care and often in more detail, because imaging is frequently normal and the symptom pattern does the talking. Headache type, vestibular and visual function, cervical involvement, sleep, mood and autonomic symptoms are reviewed individually, since several of them respond to targeted treatment.

It is planned around it. Neuropsychology, cognitive rehabilitation and physical therapy continue, and we ask your team to keep their own before-and-after measures, so any change can be attributed properly rather than credited to the most recent thing you tried.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.